| |
|
|
|
Evofem Biosciences Inc.  
|
|
3.5 0.09 (0.03%) |
02-21 13:19 |
|
Open: |
3.43 |
Pre close: |
3.41 |
Target:
|
4.34
|
|
High: |
3.59 |
Low: |
3.42 |
Resistance:
|
3.71
4.00
|
|
Volume: |
27,062 |
Market Cap: |
101M |
Support:
|
3.25
2.70
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.52
 |
MACD |
MACD(12,26):
|
-0.05  |
|
MA(20): |
3.42 |
Signal(12,26,9): |
-0.08 |
|
MA(100): |
3.66 |
Stochastic Oscillator |
%K(14,3):
|
54.07 |
|
MA(250): |
4.21 |
%D(3): |
58.38 |
|
Average Volume(K) |
3-Month: |
12353
|
52-Week |
High:
|
8.50 |
|
10-Days: |
1463 |
Low: |
1.79 |
|
RSI |
RSI(14):
|
48.95 |
Change(%): |
-52.8 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.820 |
Return on Equity (ttm) |
1220.9 |
Shares Out. (M) |
25.87 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-303.1 |
Shares Float (M) |
24.89 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
-0.02 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
148.00 |
|
Forward EPS |
-1.520 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
16.480 |
EBITDA (p.s.) |
0.000 |
P/E |
-1.92 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.21 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-51.20 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-91.30 |
P/CF |
-1.77 |
|
|
|
|
|
|
